Works matching IS 00429007 AND DT 2009 AND VI 97 AND IP 3
Results: 16
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG<sup>®</sup> after implementation of a novel prion protein (PrP<sup>Sc</sup>) removal technology and reduction of the solvent/detergent (S/D) process time.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 219, doi. 10.1111/j.1423-0410.2009.01190.x
- By:
- Publication type:
- Article
Pathogen reduction technology (Mirasol<sup>®</sup>) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 234, doi. 10.1111/j.1423-0410.2009.01193.x
- By:
- Publication type:
- Article
A randomized study of buffy coat platelets in platelet additive solution stored 1–5 versus 6–7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 254, doi. 10.1111/j.1423-0410.2009.01197.x
- By:
- Publication type:
- Article
Iron overload and toxicity: the hidden risk of multiple blood transfusions.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 185, doi. 10.1111/j.1423-0410.2009.01207.x
- By:
- Publication type:
- Article
Addendum.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Massive transfusion – evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 247, doi. 10.1111/j.1423-0410.2009.01198.x
- By:
- Publication type:
- Article
Duffy antigen expression on reticulocytes does not alter following blood loss in an autologous donation model.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 268, doi. 10.1111/j.1423-0410.2009.01203.x
- By:
- Publication type:
- Article
Extracellular 20S proteasomes accumulate in packed red blood cell units.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG<sup>®</sup>.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 226, doi. 10.1111/j.1423-0410.2009.01206.x
- By:
- Publication type:
- Article
Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 240, doi. 10.1111/j.1423-0410.2009.01199.x
- By:
- Publication type:
- Article
Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 260, doi. 10.1111/j.1423-0410.2009.01200.x
- By:
- Publication type:
- Article
Blood group genotyping: from patient to high-throughput donor screening.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 198, doi. 10.1111/j.1423-0410.2009.01209.x
- By:
- Publication type:
- Article
Variant Creutzfeldt-Jakob disease and exposure to fractionated plasma products.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 207, doi. 10.1111/j.1423-0410.2009.01205.x
- By:
- Publication type:
- Article
Erythrocyte survival tests in cases of anti-AnWj antibodies.
- Published in:
- 2009
- By:
- Publication type:
- Letter
A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 211, doi. 10.1111/j.1423-0410.2009.01222.x
- By:
- Publication type:
- Article
Diary of Events.
- Published in:
- Vox Sanguinis, 2009, v. 97, n. 3, p. 278, doi. 10.1111/j.1423-0410.2009.01254.x
- Publication type:
- Article